Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| PACIRA (NASDAQ: PCRX) | Delayed: 36.38 +0.05 (0.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.33 | 52 Week High | $80.25 | |||
| Open | $36.38 | 52 Week Low | $30.25 | |||
| Day High | $36.40 | P/E | N/A | |||
| Day Low | $36.35 | EPS | $-2.08 | |||
| Volume | 109,192 | |||||
| (NASDAQ: VTRS) | Delayed: 18.54 +0.09 (0.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.45 | 52 Week High | $ | |||
| Open | $18.45 | 52 Week Low | $ | |||
| Day High | $18.66 | P/E | N/A | |||
| Day Low | $18.35 | EPS | $ | |||
| Volume | 597,230 | |||||
